Guardant Health, Inc. - Common Stock (NQ:GH)

177.80 +3.05 (+1.75%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stephens Starts Coverage On This Precision Oncology Company With 66% Upside ↗

October 06, 2022

Via Benzinga

Analyst Ratings for Guardant Health ↗

October 06, 2022

Analysts have provided the following ratings for Guardant Health (NASDAQ:GH) within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022 ↗

October 06, 2022

Upgrades

Via Benzinga

Analyst Ratings for Guardant Health ↗

August 25, 2022

Within the last quarter, Guardant Health (NASDAQ:GH) has observed the following analyst ratings:

Via Benzinga

Recap: Guardant Health Q2 Earnings ↗

August 04, 2022

Guardant Health (NASDAQ:GH) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:03 PM. Here's what investors need to know about the announcement.

Via Benzinga

Netflix, Biogen And Other Big Gainers From Wednesday ↗

September 29, 2022

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗

September 27, 2022

Via Benzinga

COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗

September 23, 2022

The World Health Organization (WHO) warned that it struggles to identify and

Via Benzinga

US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing ↗

September 14, 2022

Via Benzinga

Biden Administration Pushes 'Cancer Moonshot' Initiative: Report ↗

September 13, 2022

President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it." The...

Via Benzinga

Guardant Health Introduces GuardantINFINITY™ Smart Liquid Biopsy for Research Use to Help Bring New Cancer Therapies to Patients Sooner

September 09, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health to showcase new data at ESMO 2022 demonstrating utility of its portfolio of blood tests for advanced-stage cancer patients

September 06, 2022

From Guardant Health, Inc.

Via Business Wire

Lululemon, Smartsheet, Okta, And Other Big Gainers From Friday ↗

September 06, 2022

U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Friday. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Guardant Health Expands Strategic Collaboration With Merck KGaA, Darmstadt, Germany, to Help Accelerate Development of Precision Oncology Therapeutics

August 31, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference

August 29, 2022

From Guardant Health, Inc.

Via Business Wire

No More Free COVID-19 At-Home Tests, Federal Government Says ↗

August 29, 2022

CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au

Via Benzinga

Why Micro Focus International Is Trading Higher By Around 94%; Here Are 28 Stocks Moving Premarket ↗

August 26, 2022

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Guardant Health's Return On Capital Employed Insights ↗

August 23, 2022

Benzinga Pro data, Guardant Health (NASDAQ:GH) reported Q2 sales of $109.14 million. Earnings fell to a loss of $229.43 million, resulting in a 86.18% decrease from last quarter.

Via Benzinga

Guardant Health Expands Use of Guardant Reveal™ Liquid Biopsy Test for Residual Disease Detection and Recurrence Monitoring to Include Early-Stage Breast and Lung Cancers

August 15, 2022

From Guardant Health, Inc.

Via Business Wire

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

August 12, 2022

Via Benzinga

Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation ↗

August 12, 2022

Via Benzinga

Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for Daiichi Sankyo and AstraZeneca’s ENHERTU® for Treatment of NSCLC Patients With Activating HER2 Mutations

August 12, 2022

From Guardant Health, Inc.

Via Business Wire

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference

August 08, 2022

From Guardant Health, Inc.

Via Business Wire

Uber Dumped By Large Shareholder As Billionaire's 'Vision' Suffers Investment Struggles ↗

August 08, 2022

After reporting one of its largest losses ever, SoftBank Group Corp (OTC: SFTBY) has turned to alternative methods to regain lost capital.

Via Benzinga

Guardant Health and Blueprint Medicines present real-world data identifying EGFR C797X mutation as most common resistance mechanism to osimertinib therapy at IASLC 2022 World Conference on Lung Cancer

August 08, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces New Data from its Portfolio of Blood Tests and GuardantINFORM™ Real-World Clinical-Genomic Platform at IASLC 2022 World Conference on Lung Cancer

August 05, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Reports Second Quarter 2022 Financial Results

August 04, 2022

From Guardant Health, Inc.

Via Business Wire

Guardant Health Receives Medicare Coverage for Guardant Reveal™ Test

August 02, 2022

From Guardant Health, Inc.

Via Business Wire

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.